Dolby Laboratories (NYSE:DLB – Get Free Report) updated its first quarter 2027 earnings guidance on Tuesday. The company provided earnings per share guidance of 0.410-0.560 for the period, compared to the consensus estimate of 1.060. The company issued revenue guidance of $285.0 million-$305.0 million, compared to the consensus revenue estimate of $358.3 million. Dolby Laboratories also updated its FY 2027 guidance to 4.270-4.420 EPS.
Dolby Laboratories Price Performance
Shares of DLB opened at $56.88 on Thursday. The firm has a market capitalization of $5.33 billion, a P/E ratio of 21.07 and a beta of 0.79. Dolby Laboratories has a one year low of $48.26 and a one year high of $69.95. The business has a fifty day moving average of $60.80 and a 200 day moving average of $59.37.
Dolby Laboratories (NYSE:DLB – Get Free Report) last posted its earnings results on Tuesday, November 17th. The electronics maker reported $1.25 earnings per share for the quarter, beating analysts’ consensus estimates of $1.20 by $0.05. The company had revenue of $373.54 million for the quarter, compared to the consensus estimate of $372.76 million. Dolby Laboratories had a return on equity of 11.78% and a net margin of 18.14%. Dolby Laboratories’s revenue was up 21.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.99 earnings per share. Dolby Laboratories has set its Q1 2027 guidance at 0.410-0.560 EPS and its FY 2027 guidance at 4.270-4.420 EPS. Analysts expect that Dolby Laboratories will post 3.36 EPS for the current fiscal year.
Dolby Laboratories Increases Dividend
Dolby Laboratories announced that its board has approved a stock buyback plan on Thursday, July 30th that allows the company to repurchase $350 million in outstanding shares. This buyback authorization allows the electronics maker to purchase up to 7% of its stock through open market purchases. Share buyback plans are typically a sign that the company’s board believes its shares are undervalued.
Wall Street Analysts Forecast Growth
Several brokerages have recently weighed in on DLB. Rosenblatt Securities lowered their price objective on shares of Dolby Laboratories from $85.00 to $80.00 and set a “buy” rating on the stock in a research note on Monday. Weiss Ratings upgraded shares of Dolby Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, September 9th. Zacks Research upgraded shares of Dolby Laboratories from a “strong sell” rating to a “hold” rating in a research report on Friday, November 13th. Finally, Wall Street Zen cut shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. Two research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $85.00.
View Our Latest Research Report on Dolby Laboratories
Insider Activity at Dolby Laboratories
In other Dolby Laboratories news, SVP John Couling sold 7,667 shares of the firm’s stock in a transaction that occurred on Thursday, October 1st. The shares were sold at an average price of $58.78, for a total transaction of $450,666.26. Following the sale, the senior vice president owned 166,803 shares in the company, valued at approximately $9,804,680.34. This trade represents a 4.39% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Ryan Nicholson sold 1,183 shares of Dolby Laboratories stock in a transaction that occurred on Tuesday, August 25th. The shares were sold at an average price of $65.28, for a total transaction of $77,226.24. Following the transaction, the chief accounting officer directly owned 34,453 shares in the company, valued at $2,249,091.84. This represents a 3.32% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 16,517 shares of company stock valued at $995,963 over the last three months. 37.93% of the stock is currently owned by insiders.
Key Dolby Laboratories News
Investors following DLB have been watching these news items:
- Positive Sentiment: Dolby raised its quarterly dividend 8.3%, from $0.36 to $0.39 per share, equivalent to $1.56 annually. The company also noted that advanced audio and imaging patents generated more than half of licensing revenue, while its Video Distribution Patent Program grew to 47 licensors. Dolby: 3 key takeaways for long-term investors
- Negative Sentiment: Fiscal 2027 revenue guidance of about $1.4 billion was below the roughly $1.5 billion consensus. Q1 guidance was a bigger concern: revenue of $285 million–$305 million versus $358.3 million expected, and EPS of $0.41–$0.56 versus $1.06 expected. The outlook points to near-term headwinds despite the strong quarter. Dolby among stocks moving lower in premarket
- Negative Sentiment: Analysts trimmed price targets: Barrington lowered its target from $90 to $80 but kept an Outperform rating, while Rosenblatt cut its target from $85 to $80 and retained a Buy rating. DLB also slipped below its 200-day moving average after an analyst downgrade, adding technical pressure. Barrington cuts Dolby price target
Dolby Laboratories Company Profile
Dolby Laboratories, Inc. develops audio and imaging technologies used in entertainment and consumer electronics. Its offerings include Dolby Atmos immersive audio, Dolby Vision high-dynamic-range imaging, and technologies for encoding, delivering and reproducing sound and video. The company licenses its technologies to manufacturers and content businesses across areas such as film, television, streaming, gaming and mobile devices. Dolby also supports cinema experiences through technologies and services including Dolby Cinema.
Read More
- Five stocks we like better than Dolby Laboratories
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
